Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA priority review
Biotech
‘Real momentum’ or ‘absurd’? Trump stance shakes up psychedelics
The Trump administration's support could launch psychedelics across the regulatory finish line or doom the field to perpetual questions of legitimacy.
Darren Incorvaia
May 4, 2026 3:30am
Senate hearing takes aim at FDA's rare disease review process
Feb 26, 2026 3:50pm
Fierce Pharma
FDA’s rare pediatric voucher program revived by funding bill
Feb 4, 2026 3:12pm
2 lawmakers push for answers as questions swirl over FDA program
Nov 25, 2025 10:30am
FDA unveils hiring spree, new comms program to speed reviews
Nov 21, 2025 11:43am
FDA aims for September approval decision for Stealth's drug
Aug 21, 2025 10:15am
